ADVIA Centaur Anti-Thyroglobulin II (aTgII)— 510(k) K250816
Substantially EquivalentSiemens Healthcare Diagnostics, Inc.
FDA 510(k) clearance K250816 for ADVIA Centaur Anti-Thyroglobulin II (aTgII), Substantially Equivalent on 2025-12-04. Applicant: Siemens Healthcare Diagnostics, Inc..
Clearance details
- Applicant
- Siemens Healthcare Diagnostics, Inc.
- Product code
- Code JNL
- Advisory panel
- Immunology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Tarrytown, NJ, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.